within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05A_AgentsForTreatmentOfHemorrhoidsAndAnalFissuresFo.C05AA12_Triamcinolone;

model Triamcinolone_1
  extends Pharmacolibrary.Drugs.ATC.C.C05AA12_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Triamcinolone_1</td></tr><tr><td>ATC code:</td><td>C05AA12_1</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid with glucocorticoid activity, used for its anti-inflammatory and immunosuppressive effects. It is indicated for various conditions including allergic reactions, dermatological diseases, and as a local treatment for joint inflammation. It is approved and widely used clinically in multiple formulations.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for triamcinolone administered topically as used under ATC code C05AA12. No direct publications found for topical formulation.</p><h4>References</h4><ol><li><p>Ramadas, AA, et al., &amp; Kumar, SP (2016). Systemic absorption of 0.1% triamcinolone acetonide as topical application in management of oral lichen planus. <i>Indian journal of dental research : official publication of Indian Society for Dental Research</i> 27(3) 230â€“235. DOI:<a href=\"https://doi.org/10.4103/0970-9290.186237\">10.4103/0970-9290.186237</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27411649/\">https://pubmed.ncbi.nlm.nih.gov/27411649</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Triamcinolone_1;
